C&L leads
Technology scouting, opportunity assessment, market intelligence, market-entry strategy, manufacturer relationships and commercial development.
What We Do
A local pathway shaped around each opportunity.
Medical technologies differ in clinical use, regulatory requirements, purchasing dynamics, adoption barriers and commercial models.
C&L does not apply the same market-entry formula to every technology. We begin by understanding the opportunity and determining what would need to be true for it to make sense in Brazil.
- 01
Discover
We identify differentiated medical technologies and manufacturers whose Brazilian potential merits deeper evaluation.
- 02
Assess
We examine the opportunity across the dimensions that can materially affect its viability: clinical relevance, differentiation and alternatives, available evidence, Brazilian market context, regulatory considerations, adoption pathway, commercial economics and partnership structure.
- 03
Structure
Where the opportunity remains compelling, we work with the manufacturer to define an appropriate model for Brazil.
Depending on the technology, this may involve market-entry strategy, regulatory coordination, commercial development, local representation structure, import and distribution planning, launch preparation, manufacturer-supported product education and ongoing market development.
The appropriate structure depends on the technology and the partnership.
- 04
Develop
Where there is alignment, the focus shifts from assessment to building the relationships, operating structure and commercial foundation necessary to develop the Brazilian opportunity responsibly.
ROLES & RESPONSIBILITIES
An appropriate structure for each opportunity.
C&L coordinates
Regulatory, legal, compliance, import/logistics and other specialist work required by the technology, together with appropriate manufacturer-led product and clinical education.
Depending on the partnership
Local representation, importation, distribution, commercialization, launch activities and continued market development may form part of the agreed operating model.
The appropriate structure depends on the technology, regulatory requirements and responsibilities agreed between the parties.
BRAZIL · MEDICAL TECHNOLOGY · PARTNERSHIP